USPTO serial 79430823
WASKYRA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 24, 2026
- Examiner
- OSGOOD, KRYSTINA E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with WASKYRA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for gene therapy for the treatment of Wiskott-Aldrich syndrome; medicine, namely, Etuvetidigene autotemcel; pharmaceutical preparations for treating Wiskott-Aldrich syndrome | ACTIVE | — |
| 042 | Biological research, clinical research in the field of gene therapy and medical research; medical research laboratory services; research and development of vaccines and medicines; scientific research services in the preparation of biological samples for testing and analysis in research laboratories; genetic scientific research; scientific research and development; pharmaceutical drug development services; providing information on clinical studies via an interactive website; medical and scientific research, namely, conducting clinical trials for others; DNA screening for scientific research purposes; design and development of computer hardware and software; research and development of new products for others; conducting technical scientific feasibility project studies; rental of computer software for collecting, analysing and organizing data in the field of medical research and treatment of genetic diseases; computer programming; conversion of computer programs and data, other than physical conversion; recovery of computer data; quality control for others; material testing; engineering, namely, surveying; conversion of data or documents from physical to electronic media; bacteriological research; hosting of communication computer platforms on the internet; programming of software for Internet platforms; pharmaceutical products development; scientific research services; scientific laboratory services; structural and functional analysis of genomes; development of pharmaceutical preparations and medicines; scientific research consultancy in relation to assessments, estimates, and researches in science and technology rendered by engineers; providing information in the nature of evaluations and estimations in the field of medical research; industrial research and biological analysis in the field of health; providing of imaging and physiology platforms, namely, providing temporary use of online non-downloadable software for analysing medical imaging; research and development of pharmaceuticals and veterinary and hygiene preparations for others; product development and testing of pharmaceuticals in the validation of biological tests, cellular tests, genetic tests and immunological tests; gene therapy research and scientific research | ACTIVE | — |
| 044 | Medical services; medical screening; medical assistance; medical counselling; providing news and information in the field of medicine; performing diagnosis of diseases; medical advisory services relating to degenerative diseases; medical surgical diagnostic services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic services; human hygiene and beauty care; health counselling; hospital services; nursing home services; pharmacy advice, namely, prescription management and reviews; medical imaging services; human tissue bank services; conducting of medical examinations; medical consultations; medical and health care services relating to DNA, genetics and genetic testing; telemedicine services; stem cell therapy services; preparation and dispensing of medications; providing of medical information in the pharmaceutical field; medical, alternative medicinal and pharmaceutical consultancy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by FONDAZIONE TELETHON ETS
- Other trademarks owned by FONDAZIONE TELETHON ETS
- Other trademarks owned by FONDAZIONE TELETHON ETS
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named WASKYRA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 1, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 1, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 24, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 24, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 24, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 3, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 3, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 28, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 12, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 24, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 24, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 24, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 4, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 4, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 22, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 21, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 21, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 25, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 25, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 21, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |